Cargando…

Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically Ill Patients

The desired target steady-state average colistin concentration (C(ss,avg)) to balance between therapeutic effectiveness and nephrotoxicity is largely unclear. The objective of this study was to evaluate the effect of the desired target colistin C(ss,avg) on the effectiveness and safety of IV colisti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Sunmi, Chung, Eun Kyoung, Jun, Min Sun, Son, Eun Sun, Rhie, Sandy Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584744/ https://www.ncbi.nlm.nih.gov/pubmed/31217523 http://dx.doi.org/10.1038/s41598-019-44965-y

Ejemplares similares

Risk factors of colistin safety according to administration routes: Intravenous and aerosolized colistin
por: Min, Kyoung Lok, et al.
Publicado: (2018)

Quantification of Teicoplanin Using the HPLC-UV Method for Clinical Applications in Critically Ill Patients in Korea
por: Lee, Jaeok, et al.
Publicado: (2021)

Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes
por: Sanabria, Jose, et al.
Publicado: (2021)

Comparison of colistin-induced nephrotoxicity between two different formulations of colistin in critically ill patients: a retrospective cohort study
por: Feng, Jia-Yih, et al.
Publicado: (2021)

Antimicrobial Stewardship Programs in Community Health Systems Perceived by Physicians and Pharmacists: A Qualitative Study with Gap Analysis
por: Park, Sohyun, et al.
Publicado: (2019)

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
por: Zabidi, Mohd Shafie, et al.
Publicado: (2021)

Can Nebulised Colistin Therapy Improve Outcomes in Critically Ill Children with Multi-Drug Resistant Gram-Negative Bacterial Pneumonia?
por: Aygun, Fatih, et al.
Publicado: (2019)

Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment
por: Park, Yu Jin, et al.
Publicado: (2018)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011)

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
por: Wang, Sheng-Huei, et al.
Publicado: (2021)

Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer
por: Geum, Min Jung, et al.
Publicado: (2021)

Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy
por: Choi, Jae Hee, et al.
Publicado: (2021)

High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
por: Dalfino, Lidia, et al.
Publicado: (2012)

Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy
por: Yu, Xu-ben, et al.
Publicado: (2022)

Validation of a Questionnaire for Patient Awareness and the Need for a Community-Based Outpatient Antimicrobial Stewardship Program (O-ASP): A Pilot Study
por: Park, Sohyun, et al.
Publicado: (2021)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012)

Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011)

Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria
por: Choe, Junsu, et al.
Publicado: (2019)

Risk factors for the first episode of Acinetobacter baumannii resistant to colistin infection and outcome in critically ill patients
por: Mantzarlis, Konstantinos, et al.
Publicado: (2020)

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
por: Michalopoulos, Argyris S, et al.
Publicado: (2011)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022)

Critical-Illness: Combined Effects of Colistin and Vasoactive Drugs: A Pilot Study
por: Stamatiou, Rodopi, et al.
Publicado: (2023)

Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome
por: Elham, Bukhari, et al.
Publicado: (2019)

Gene networking in colistin-induced nephrotoxicity reveals an adverse outcome pathway triggered by proteotoxic stress
por: Lee, Eun Hee, et al.
Publicado: (2019)

Convulsions in a critically ill patient on hemodialysis: Possible role of low dose colistin
por: Sodhi, Kanwalpreet, et al.
Publicado: (2014)

Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014)

Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
por: Papathanakos, Georgios, et al.
Publicado: (2020)

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2020)

Commentary: Population pharmacokinetics of colistin sulfate in critically ill patients: Exposure and clinical efficacy
por: Chen, Huadong, et al.
Publicado: (2022)

The Effectiveness of Early Enteral Nutrition on Clinical Outcomes in Critically Ill Sepsis Patients: A Systematic Review
por: Moon, Sun Jae, et al.
Publicado: (2023)

Exploring New Predictors of Colistin-Associated Nephrotoxicity
por: Kim, Eun Jung, et al.
Publicado: (2018)

Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa
por: Lee, Ji-Young, et al.
Publicado: (2016)

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
por: Markou, Nikolaos, et al.
Publicado: (2003)

Emergence of isolates that are intrinsically resistant to colistin in critically ill patients: are we selecting them out?
por: Sivakumar, MN, et al.
Publicado: (2015)

485 Colistin Nephrotoxicity in Critically Ill Patients after Implementation of a New Dosing Strategy
por: Özel, Ayşe Serra, et al.
Publicado: (2014)

Once Versus Thrice Daily Colistin in Critically Ill Ptients with Multi-Drug Resistant Infections
por: Ghazaeian, Monireh, et al.
Publicado: (2017)

A Randomized Clinical Trial Evaluating the Efficacy of Colistin Loading Dose in Critically Ill Children
por: Fatehi, Shiva, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hgtobps1p97md232pbcbk19fcl